Cargando…
Data provenance and integrity of health-care systems data for clinical trials
Autores principales: | Murray, Macey L, Love, Sharon B, Carpenter, James R, Hartley, Suzanne, Landray, Martin J, Mafham, Marion, Parmar, Mahesh K B, Pinches, Heather, Sydes, Matthew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296098/ https://www.ncbi.nlm.nih.gov/pubmed/35868811 http://dx.doi.org/10.1016/S2589-7500(22)00122-4 |
Ejemplares similares
-
Accessing routinely collected health data to improve clinical trials: recent experience of access
por: Macnair, Archie, et al.
Publicado: (2021) -
What is the association of COVID-19 with heart attacks and strokes?
por: Mafham, Marion, et al.
Publicado: (2021) -
Making a distinction between data cleaning and central monitoring in clinical trials
por: Love, Sharon B, et al.
Publicado: (2021) -
A DELPHI study priority setting the remaining challenges for the use of routinely collected data in trials: COMORANT-UK
por: Williams, Adam D. N., et al.
Publicado: (2023) -
Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022)